Lack of pharmaceutical reconciliation and adherence is the key cost driver in healthcare for privately funded insurance plans, hospitals and the US government.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free